In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Arcutis Biotherapeutics Inc (NASDAQ: ARQT) was $15.49 for the day, up 7.72% from the previous closing price of $14.38. In other words, the price has increased by $7.72 from its previous closing price. On the day, 2.57 million shares were traded.
Ratios:
Our analysis of ARQT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.97 and its Current Ratio is at 4.15. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Burnett Patrick sold 2,819 shares for $13.03 per share. The transaction valued at 36,735 led to the insider holds 167,043 shares of the business.
Burnett Patrick sold 954 shares of ARQT for $12,673 on Mar 04 ’25. The insider now owns 166,089 shares after completing the transaction at $13.28 per share. On Mar 03 ’25, another insider, Watanabe Todd Franklin, who serves as the insider of the company, sold 20,880 shares for $13.03 each. As a result, the insider received 272,089 and left with 934,249 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.35 while its Price-to-Book (P/B) ratio in mrq is 11.59.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $16.20, while it has fallen to a 52-week low of $6.99. The 50-Day Moving Average of the stock is 14.40%, while the 200-Day Moving Average is calculated to be 42.45%.
Shares Statistics:
A total of 117.85M shares are outstanding, with a floating share count of 104.14M. Insiders hold about 12.22% of the company’s shares, while institutions hold 101.79% stake in the company.
